Literature DB >> 7597115

Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

D D Dougherty1, C E Sortwell, J Sagen.   

Abstract

Previous studies in our laboratory have demonstrated the ability of monoaminergic transplants in the rat frontal cortex to produce antidepressive activity in both the learned helplessness model and the forced swimming test, as well as to increase monoamine levels in the implanted frontal cortex. These findings implicate increased cortical levels of norepinephrine (NE) and serotonin (5-HT) in the antidepressive activity of monoaminergic transplants. The goal of the present study was to characterize the pharmacologic mechanisms involved in the monoaminergic graft-induced antidepressive activity. Immobility scores in the forced swimming test (FST) were assessed after transplantation of 5-HT-containing pineal gland tissue, NE-containing adrenal medullary tissue, a combination of both tissues, or sciatic nerve (control) into the rat frontal cortex and compared to non-transplanted and chronic imipramine-treated rats. Monoaminergic transplants and imipramine treatment significantly reduced immobility scores in the FST in contrast to control transplanted or untreated animals. All groups were assessed pharmacologically with the adrenergic antagonists phentolamine (alpha) and propranolol (beta), and serotonergic antagonists metergoline (5-HT1/5-HT2) and pirenperone (5-HT2). Serotonergic antagonists, particularly the 5HT2 antagonist, blocked the reduction in FST immobility induced by the pineal implants. Adrenergic antagonists not only blocked FST immobility reductions in adrenal medullary grafted animals, but over-compensated for the adrenal transplants, producing a large increase in immobility. The FST reduction induced by pineal and adrenal cografts was blocked by all four monoaminergic antagonists. FST immobility scores in control transplanted and non-transplanted animals were not altered by any of the antagonists. The immobility reduction produced by chronic imipramine treatment was blocked significantly only by propranolol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7597115     DOI: 10.1007/BF02245244

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Behavioral models in mice. Implication of the alpha noradrenergic system.

Authors:  M Hascoët; M Bourin; J Bradwejn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1991       Impact factor: 5.067

2.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

3.  Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids.

Authors:  R J Wurtman; J Axelrod
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

4.  Repeated treatment with amitriptyline reduces immobility in the behavioural 'despair' test in rats by activating dopaminergic and beta-adrenergic mechanisms.

Authors:  F Borsini; E Nowakowska; L Pulvirenti; R Samanin
Journal:  J Pharm Pharmacol       Date:  1985-02       Impact factor: 3.765

5.  Pharmacologic characterization of opioid peptide release from chromaffin cell transplants using a brain slice superfusion method.

Authors:  J D Ortega; J Sagen
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 6.  A role for 5-HT in the action of antidepressant drugs.

Authors:  P J Cowen
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 7.  Overview: toward a dysregulation hypothesis of depression.

Authors:  L J Siever; K L Davis
Journal:  Am J Psychiatry       Date:  1985-09       Impact factor: 18.112

8.  Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants.

Authors:  F Borsini; C Bendotti; V Velkov; R Rech; R Samanin
Journal:  J Pharm Pharmacol       Date:  1981-01       Impact factor: 3.765

Review 9.  Monoaminergic mechanisms in affective disorders.

Authors:  E Syvälahti
Journal:  Med Biol       Date:  1987

10.  Monoaminergic neural transplants prevent learned helplessness in a rat depression model.

Authors:  J Sagen; C E Sortwell; G D Pappas
Journal:  Biol Psychiatry       Date:  1990-12-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.